<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[the burrill report Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/the+burrill+report.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to the burrill report]]></description>
	<s:counts start="0" returned="20" found="21" />
	<language>en-us</language>
	<item>
		<title><![CDATA[BlueFire, Archer-Daniels to Benefit from Federal Biorefinery Millions]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177924-bluefire-archer-daniels-to-benefit-from-federal-biorefinery-millions%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Federal funding intended to advance 19 biorefinery projects is flowing again from the U.S. Departments of Energy and Agriculture. Together, the two agencies will spend $564 million to accelerate the construction and operation of pilot, demonstration, and commercial scale facilities, according to the government. Private...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 13 Dec 2009 01:28:43 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/energy.html"><![CDATA[Energy]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/archer+daniels+midland+co..html"><![CDATA[Archer Daniels Midland Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADM</category>
		<category domain="tickers">ADM</category>
	</item>
	<item>
		<title><![CDATA[Financing Drug Discovery: Recent Deals]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175397-financing-drug-discovery-recent-deals%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  by Marie Daghlian A smattering of deals and financings marked the relatively quiet days before Thanksgiving. San Diego-based biotech Receptos closed a two-tranche $25 million series A financing. The company is focused on identifying and developing best- and first-in-class therapeutic candidates that target a family...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 26 Nov 2009 12:41:16 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[Novartis Partners with U.S. Government for Faster Flu Vaccine Manufacturing]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175396-novartis-partners-with-u-s-government-for-faster-flu-vaccine-manufacturing%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Novartis NVS and the U.S. Department of Health and Human Services will invest nearly $1 billion to build the first large cell culture-based flu vaccine manufacturing center in the United States. The new North Carolina manufacturing facility will be capable of producing up to 150...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 26 Nov 2009 12:34:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Merck Triumphs in Defense of Osteoporosis Drug ... for Now]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175394-merck-triumphs-in-defense-of-osteoporosis-drug-for-now%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Merck MRK has triumphed in the second of three key cases alleging its osteoporosis drug, Fosamax, can cause osteonecrosis of the jaw. The victory comes just two months after a similar case resulted in a mistrial when its jury deadlocked. In a summary judgment for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 26 Nov 2009 12:27:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175393-bristol-myers-squibb-sees-perfect-timing-to-divest-huge-mead-johnson-nutrition-stake%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Bristol-Myers Squibb BMY will sell its last non-biopharmaceutical holding, a majority stake in Mead Johnson Nutrition MJN, the company said. The pediatric nutrition company produces Enfamil baby formula and is a leading supplier of children&#8217;s nutritional products globally. Bristol-Myers&#8217; move, part of a wider healthcare...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 26 Nov 2009 12:16:58 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/bristol-myers+squibb+co..html"><![CDATA[Bristol-Myers Squibb Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
		<category domain="tickers">BMY</category>
	</item>
	<item>
		<title><![CDATA[Vitamin Beats Statin: Is Merck's Zetia in Trouble?]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174615-vitamin-beats-statin-is-merck-s-zetia-in-trouble%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits: A small study is causing a big splash in the multi-billion dollar world of cholesterol treatments. The test, pitting a prescription form of the B vitamin niacin against the prescription drug ezetimibe, found that niacin significantly shrank artery walls when taken in combination with a statin....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 20 Nov 2009 04:22:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity']]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173420-sanofi-aventis-to-establish-venture-capital-fund-looking-for-right-brain-activity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  By Marie Daghlian Chris Viehbacher, CEO of Sanofi-Aventis SNY, said his company will establish a venture capital fund, joining an ever-growing queue of pharma venture capital funds seeking to gain better access biotech innovation. Viehbacher confirmed the French drugmaker&#8217;s plans in comments made at an...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 15 Nov 2009 07:50:56 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/regeneron+pharmaceuticals+inc..html"><![CDATA[Regeneron Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">REGN</category>
		<category domain="tickers">REGN</category>
	</item>
	<item>
		<title><![CDATA[Biotech Blooms at Eli Lilly]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172104-biotech-blooms-at-eli-lilly%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Pharmaceutical giant Eli Lilly LLY opened a new state-of-the-art biotechnology center in San Diego, part of an ongoing effort by the drugmaker to transform itself into a biotech titan. The move follows a relocation of its ImClone headquarters to a new biopharmaceutical research cluster in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 08:14:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[China Is Growth Market for Novartis]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F172103-china-is-growth-market-for-novartis%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  The Swiss pharmaceutical giant Novartis NVS said it will invest $1 billion in China over the next five years including a significant expansion of the company&#8217;s biomedical research institute in Shanghai. On the heels of the announcement, the company also said it agreed to acquire...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 08:12:57 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Lilly Hopes New San Diego Facility Will Be 'a Biotechnology Powerhouse']]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F170348-lilly-hopes-new-san-diego-facility-will-be-a-biotechnology-powerhouse%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Pharmaceutical giant Eli Lilly LLY opened a new state-of-the-art biotechnology center in San Diego, part of an ongoing effort by the drugmaker to transform itself into a biotech titan. The move follows a relocation of its Imclone headquarters to a new biopharmaceutical research cluster in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 01 Nov 2009 01:12:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[GE's New Fund Hopes to Help 'Shape the Future of Healthcare']]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F168425-ge-s-new-fund-hopes-to-help-shape-the-future-of-healthcare%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  The industrial giant GE plans to boost its already sizable presence in the healthcare arena with the establishment of the &#8220;GE Healthymagination Fund,&#8221; a $250 million equity fund that will make investments in healthcare technology companies. The fund will invest in companies globally that have...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 23 Oct 2009 12:42:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/general+electric+co..html"><![CDATA[General Electric Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GE</category>
		<category domain="tickers">GE</category>
	</item>
	<item>
		<title><![CDATA[Little Difference Between Roche's Avastin and Lucentis for Macular Degeneration]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F167142-little-difference-between-roche-s-avastin-and-lucentis-for-macular-degeneration%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  By Kristi Eaton A new study shows that a cancer drug is no different in effectiveness as a gold standard for macula degeneration. Researchers from Boston University School of Medicine and the VA Boston Healthcare System discovered there was no difference in efficacy between Genentech's...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 18 Oct 2009 06:06:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
	</item>
	<item>
		<title><![CDATA[A Depressed Housing Market: Foreclosures Spark Mental Health Crisis]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F157756-a-depressed-housing-market-foreclosures-spark-mental-health-crisis%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  By Kristi Eaton     The high number of foreclosures as a result of the collapse of the housing market has become not only a financial problem, but a mental health one as well. A new University of Pennsylvania School of Medicine study...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 23 Aug 2009 05:56:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
	</item>
	<item>
		<title><![CDATA[Ending Pay-For-Delay Generic Drug Deals]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145534-ending-pay-for-delay-generic-drug-deals%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Stopping manufacturers of brand-name drugs from paying potential generic competitors to stay out of the market would save consumers $3.5 billion a year, says the U.S. Federal Trade Commission. FTC Chairman Jon Leibowitz says that eliminating these so-called &#8220;pay-for-delay&#8221; settlements between brand and generic pharmaceutical...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 26 Jun 2009 03:15:40 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
	</item>
	<item>
		<title><![CDATA[No Recession Seen in Medical Costs]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F144413-no-recession-seen-in-medical-costs%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Driven by increasing use of healthcare and other trends, U.S. medical costs are expected to grow by 9 percent in 2010, once again far outstripping the rise in inflation and employee wages, a new report says. The increase is expected to be lower than the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 21 Jun 2009 05:09:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
	</item>
	<item>
		<title><![CDATA[Life Science Looks to Big Pharma for Funding as Caution Still Reigns]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F143121-life-science-looks-to-big-pharma-for-funding-as-caution-still-reigns%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  By MARIE DAGHLIAN Last week's flurry of public-share offerings must have been a blip on the radar screen, as most life sciences companies look to private investors for much needed cash. And while the number of PIPEs and venture-capital financings continues at a fairly good...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Mon, 15 Jun 2009 12:23:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">DNA,MRK</category>
	</item>
	<item>
		<title><![CDATA[Ethanol Makers Still Trying to Catch a Break from Banks, Debt Holders]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141801-ethanol-makers-still-trying-to-catch-a-break-from-banks-debt-holders%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits: by MARIE DAGHLIAN A combination of lower oil prices and challenging financial markets continues to spell disaster for U.S. ethanol companies, with another 10 providers of this first-generation biofuel going belly up in the first five months of 2009. Among the latest was Pacific Ethanol PEIX,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Sun, 07 Jun 2009 04:48:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/energy.html"><![CDATA[Energy]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/pacific+ethanol+inc..html"><![CDATA[Pacific Ethanol Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/verenium+corp..html"><![CDATA[Verenium Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PEIX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRNM</category>
		<category domain="tickers">PEIX,VRNM</category>
	</item>
	<item>
		<title><![CDATA[Exelixis Suggests Creativity in Finding Cash for Biotechs in Rough Times]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F139576-exelixis-suggests-creativity-in-finding-cash-for-biotechs-in-rough-times%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  by ERIC WAHLGREN There may be no summer lovin&#8217; for biotechs. By most accounts, investors will remain tight-fisted with their cash for some time, opening up their wallets for only the most promising investments. In a sign of how devastating the global economic crisis has...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 26 May 2009 03:13:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/exelixis+inc..html"><![CDATA[Exelixis Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EXEL</category>
		<category domain="tickers">EXEL</category>
	</item>
	<item>
		<title><![CDATA[Merck, CIGNA Prove It Pays to Be Healthy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F139110-merck-cigna-prove-it-pays-to-be-healthy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits:  Aware of recent studies which showed that paying people to lose weight and quit smoking actually works, CIGNA CI and Merck MRK have decided to launch a program that pays CIGNA beneficiaries to improve their diabetes control.  And if they happen to take Merck&#8217;s...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Fri, 22 May 2009 12:28:03 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/cigna+corp..html"><![CDATA[CIGNA Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">CI,MRK</category>
	</item>
	<item>
		<title><![CDATA[Disney Aiming to Crack Pre-Teen Boys Market]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F138697-disney-aiming-to-crack-pre-teen-boys-market%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[The Burrill Report submits: The Walt Disney Company DIS wants a bigger piece of the action in the pre-teen boy market, so it hired an anthropologist to sort through the dresser drawers of a 12 year-old.  Venturing into territory never before seen by human eyes, much less smelled by...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Wed, 20 May 2009 05:53:56 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/media.html"><![CDATA[Media]]></category>
		<category domain="http://resources.bnet.com/topic/the+burrill+report.html"><![CDATA[The Burrill Report]]></category>
		<category domain="http://resources.bnet.com/topic/the+walt+disney+co..html"><![CDATA[The Walt Disney Co.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DIS</category>
		<category domain="tickers">DIS</category>
	</item>
</channel>
</rss>
